| CBL is highly expressed in breast cancer cells and significantly inhibits transforming growth factor-beta (TGF-beta) tumor suppressive activity. | breast, |
| gain-of-function mutations of c-cbl tumour suppressor associated with acquired uniparental disomy in the pathogenesis of some myeloid cancers | None |
| C-CBL is likely to play a tumor suppressive role by antagonizing a robust oncogenic signaling driven by c-Src. | None |
| Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl. | colorectal, |
| c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms. | colorectal, |
| Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. | leukemia, |
| A rearrangement of the c-cbl proto-oncogene in HUT78 T-lymphoma cells results in a truncated protein. | lymphoma, |
| Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?. | leukemia, |
| Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts. | sarcoma, |
| Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. | neoplasm, |
| Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism. | leukemia, |
| Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia. | lymphoma,leukemia, |
| Somatic mutations were identified in cbl oncogene protein in children with childhood acute lymphoblastic leukemia that involved deletions affecting the intron/exon boundaries of exon 8 and abolishing E3 ligase function. | leukemia, |
| Data suggest that EPHA2 (ephrin type-A receptor 2) regulates polyubiquitination via proto-oncogene protein c-CBL, phosphorylation of clathrin, integrin signal transduction, and endocytosis of Kaposi sarcoma-associated herpesvirus into fibroblasts. | sarcoma, |
| Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins. | leukemia, |
| Up-regulation of c-Cbl suggests its potential role as oncogene in primary colorectal cancer. | colorectal, |
| v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. | lymphoma, |
| The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma cells. | lymphoma, |
| The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase. | None |
| The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases. | None |